Bluejay Diagnostics, Inc. Investing Cash Flow
Bluejay Diagnostics, Inc. (BJDX) reported Investing Cash Flow of -$158.09 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-12
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$142.77K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$15.31K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was -$1.13K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was -$227.00.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$173.74K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$306.78K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$704.17K.
- Bluejay Diagnostics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$1.20M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$142.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$158.09K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$15.31K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$173.74K 10-K · filed 2026-03-06 | |||
| 2024-12-31 | -$1.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$1.35K derived: sum of 2 quarters · filed 2026-03-06 | -$271.35K derived: sum of 3 quarters · filed 2026-03-06 | -$306.78K 10-K · filed 2026-03-06 |
| 2024-09-30 | -$227.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$270.23K derived: sum of 2 quarters · filed 2025-11-07 | -$305.66K 10-Q · filed 2025-11-07 | -$393.55K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$305.43K 10-Q · filed 2025-08-07 | -$393.32K derived: sum of 3 quarters · filed 2025-08-07 | -$467.82K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$35.43K 10-Q · filed 2025-05-13 | -$123.33K derived: sum of 2 quarters · filed 2025-05-13 | -$197.82K derived: sum of 3 quarters · filed 2025-05-13 | -$398.93K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$87.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$162.39K derived: sum of 2 quarters · filed 2025-03-31 | -$363.50K derived: sum of 3 quarters · filed 2025-03-31 | -$704.17K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$74.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$275.60K derived: sum of 2 quarters · filed 2024-11-07 | -$616.27K 10-Q · filed 2024-11-07 | -$854.48K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$201.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$541.77K 10-Q · filed 2024-08-14 | -$779.98K derived: sum of 3 quarters · filed 2024-08-14 | -$1.57M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$340.67K 10-Q · filed 2024-05-15 | -$578.88K derived: sum of 2 quarters · filed 2024-05-15 | -$1.37M derived: sum of 3 quarters · filed 2024-05-15 | -$1.49M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$238.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.03M derived: sum of 2 quarters · filed 2024-03-28 | -$1.15M derived: sum of 3 quarters · filed 2024-03-28 | -$1.20M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$791.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$914.72K derived: sum of 2 quarters · filed 2023-11-09 | -$961.06K 10-Q · filed 2023-11-09 | -$978.80K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$123.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$169.60K 10-Q · filed 2023-08-14 | -$187.33K derived: sum of 3 quarters · filed 2023-08-14 | -$191.61K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$46.35K 10-Q · filed 2023-05-11 | -$64.08K derived: sum of 2 quarters · filed 2023-05-11 | -$68.36K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$17.73K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$22.01K derived: sum of 2 quarters · filed 2023-03-20 | -$23.95K 10-K · filed 2023-03-20 | |
| 2021-09-30 | -$4.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$6.21K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$1.93K 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |